Elevation Oncology logo

Elevation Oncology

We are focused on discovering and developing selective cancer therapies to treat patients across a range of solid tumors

5 employees · est. 2019 · Boston, United States

VS
Pheon Therapeutics logo

Pheon Therapeutics

Pheon is an Antibody-Drug Conjugate specialist developing next generation ADCs for a range of hard-to-treat cancers.

27 employees · est. 2022 · London, United Kingdom

Elevation Oncology is the older company (2019 vs 2022); Pheon Therapeutics is the larger of the two.

Side-by-Side Comparison

Elevation Oncology Pheon Therapeutics
Founded
2019 older 2022
Headquarters
Boston, United States London, United Kingdom
Employees
5 27 larger
Industry
Biopharma, Biotechnology, Health Care Biotechnology, Health and Wellness, Life Sciences
Funding Stage
Acquired Series B
Total Funding
$232.95M $188.00M
Funding Rounds
8 4
Services
Not tracked yet Development of Antibody-Drug Conjugates, Clinical Development of Cancer Therapies, Research in Oncology
Target Customers
Not tracked yet Healthcare Professionals, Oncologists, Cancer Treatment Centers, Pharmaceutical Distributors
Taxonomy
Oncology Research, Cancer Therapies, Solid Tumors, Antibody Drug Conjugate, Claudin 18.2, Genomic Tests, NRG1 Fusions, Clinical Trials, Drug Development, Precision Medicine Antibody-Drug Conjugates (ADCs), Oncology, Hard-to-Treat Cancers, ADC Development, Monoclonal Antibodies, Proprietary Payload Platform, Drug Discovery, Solid Tumors, Novel Mechanism Of Action, Clinical Strategy, Medicinal Chemistry, Healthcare Investment, Pharmaceutical Research
Website
elevationoncology.com pheontx.com
Elevation Oncology logo

About Elevation Oncology

Elevation Oncology, founded in 2019, is a pioneering oncology company with a focus on discovering and developing selective cancer therapies for patients with various solid tumors and significant unmet medical needs. The company's slogan, "We are focused on discovering and developing selective cancer...

Pheon Therapeutics logo

About Pheon Therapeutics

Pheon Therapeutics, founded in 2022, is a promising player in the biotechnology, health and wellness, and life sciences sectors, with headquarters in the United Kingdom. The company specializes in developing next-generation Antibody-Drug Conjugates (ADCs) to tackle hard-to-treat cancers, as highligh...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Elevation Oncology and Pheon Therapeutics — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Elevation Oncology and Pheon Therapeutics — by email.

Frequently Asked Questions

Elevation Oncology — We are focused on discovering and developing selective cancer therapies to treat patients across a range of solid tumors. Pheon Therapeutics — Pheon is an Antibody-Drug Conjugate specialist developing next generation ADCs for a range of hard-to-treat cancers.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Elevation Oncology has raised $232.95M while Pheon Therapeutics has raised $188.00M.
Elevation Oncology and Pheon Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Elevation Oncology with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy